middle.news
Bioxyne Secures $50 Million German Supply Contract with ADREXpharma
8:46am on Tuesday 12th of May, 2026 AEST
•
Pharmaceuticals
Read Story
Bioxyne Secures $50 Million German Supply Contract with ADREXpharma
8:46am on Tuesday 12th of May, 2026 AEST
Key Points
Two-year $50 million supply contract with ADREXpharma
$25 million minimum purchase commitment in first year
Exclusive German rights to Dr Watson® brand
Expands Bioxyne’s GMP-certified manufacturing presence in Europe
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Bioxyne (ASX:BXN)
OPEN ARTICLE